How to buy Antisense Therapeutics (ANP) shares
Learn how to easily invest in Antisense Therapeutics shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Antisense Therapeutics Limited is a drug manufacturers-specialty & generic business based in Australia. Antisense Therapeutics shares (ANP) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Antisense Therapeutics has a trailing 12-month revenue of around $577,764. If you're looking to buy shares, check out the steps below.
How to buy shares in Antisense Therapeutics
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Antisense Therapeutics. Find the share by name or ticker symbol: ANP. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Antisense Therapeutics reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Antisense Therapeutics. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Antisense Therapeutics key stats
- Compare share trading platforms
- Is Antisense Therapeutics stock a buy or sell?
- Antisense Therapeutics performance over time
- Antisense Therapeutics's financials
- How volatile are Antisense Therapeutics shares?
- Does Antisense Therapeutics pay a dividend?
- Have Antisense Therapeutics shares ever split?
- Other common questions
Antisense Therapeutics stock price (ASX:ANP)Use our graph to track the performance of ANP stocks over time.
Antisense Therapeutics shares at a glance
|52-week range||$0.091 - $0.27|
|50-day moving average||$0.1838|
|200-day moving average||$0.1961|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.015|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Antisense Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Antisense Therapeutics price performance over time
|1 week (2021-09-16)||17.14%|
|1 month (2021-08-26)||20.59%|
|3 months (2021-06-25)||7.89%|
|6 months (2021-03-26)||5.13%|
|1 year (2020-09-25)||78.26%|
|2 years (2019-09-26)||180.82%|
|3 years (2018-09-26)||978.95%|
|5 years (2016-09-26)||464.74%|
Antisense Therapeutics financials
|Gross profit TTM||$467,465|
|Return on assets TTM||-82.02%|
|Return on equity TTM||-157.15%|
|Market capitalisation||$117.8 million|
TTM: trailing 12 months
Antisense Therapeutics share dividends
We're not expecting Antisense Therapeutics to pay a dividend over the next 12 months.
Have Antisense Therapeutics's shares ever split?
Antisense Therapeutics's shares were split on a 1:10 basis on 5 November 2013. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Antisense Therapeutics shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Antisense Therapeutics shares which in turn could have impacted Antisense Therapeutics's share price.
Antisense Therapeutics share price volatility
Over the last 12 months, Antisense Therapeutics's shares have ranged in value from as little as $0.091 up to $0.27. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Antisense Therapeutics's is 0.6032. This would suggest that Antisense Therapeutics's shares are less volatile than average (for this exchange).
Antisense Therapeutics overview
Antisense Therapeutics Limited, a biopharmaceutical company, engages in the research and development of novel antisense pharmaceuticals in Australia. Its product pipeline comprises ATL1102, an antisense inhibitor of CD49d, which is in Phase II clinical trial for the treatment of multiple sclerosis, Duchenne Muscular Dystrophy, asthma, and other inflammatory indications. The company's product pipeline also includes ATL1103, a second generation antisense drug designed to block growth hormone receptor expression thereby reducing levels of the hormone insulin-like growth factor-I in the blood, as well as to treat diseases associated with excessive growth hormone action that has completed Phase II clinical trial. Antisense Therapeutics Limited was incorporated in 2000 and is based in Toorak, Australia.
Stocks similar to Antisense Therapeutics
Antisense Therapeutics in the news
Frequently asked questions
More guides on Finder
How to invest in the Cosmos Exploration IPO
Everything we know about the Cosmos Exploration IPO, plus information on how to buy in.
What is behind the bounce in the Zip Co share price?
Shares in BNPL provider Zip Co have slipped more than 13% in the last 6 months.
Why the AGL share price has rebounded today
Shares in electricity giant AGL Energy are down 60% in the last 12 months.
How to invest in the Dundas Minerals IPO
Everything we know about the Dundas Minerals IPO, plus information on how to buy in.
How to invest in the Kalgoorlie Gold Mining IPO
Everything we know about the Kalgoorlie Gold Mining IPO, plus information on how to buy in.
The best iron ore stocks on the ASX (2021)
We look at some of the biggest and best performing iron ore stocks in Australia.
Why are the CBA and WBC share prices stumbling today?
Shares in the major banks have risen more than 50% in the last 12 months.
How to buy Evergrande shares from Australia
Steps to owning and managing China Evergrande Group shares from Australia.
How to invest in the Hamelin Gold IPO
Everything we know about the Hamelin Gold IPO, plus information on how to buy in.
How to invest in the Lykos Metals IPO
Everything we know about the Lykos Metals IPO, plus information on how to buy in.
Ask an Expert